Novel biomarkers for pre-diabetes identified by metabolomics

Rui Wang-Sattler, Zhonghao Yu, Christian Herder, Ana C. Messias, Anna Floegel, Ying He, Katharina Heim, Monica Campillos, Christina Holzapfel, Barbara Thorand, Harald Grallert, Tao Xu, Erik Bader, Cornelia Huth, Kirstin Mittelstrass, Angela Döring, Christa Meisinger, Christian Gieger, Cornelia Prehn, Werner Roemisch-Margl & 23 others Maren Carstensen, Lu Xie, Hisami Yamanaka-Okumura, Guihong Xing, Uta Ceglarek, Joachim Thiery, Guido Giani, Heiko Lickert, Xu Lin, Yixue Li, Heiner Boeing, Hans Georg Joost, Martin Hrabé De Angelis, Wolfgang Rathmann, Karsten Suhre, Holger Prokisch, Annette Peters, Thomas Meitinger, Michael Roden, H. Erich Wichmann, Tobias Pischon, Jerzy Adamski, Thomas Illig

Research output: Contribution to journalArticle

338 Citations (Scopus)

Abstract

Type 2 diabetes (T2D) can be prevented in pre-diabetic individuals with impaired glucose tolerance (IGT). Here, we have used a metabolomics approach to identify candidate biomarkers of pre-diabetes. We quantified 140 metabolites for 4297 fasting serum samples in the population-based Cooperative Health Research in the Region of Augsburg (KORA) cohort. Our study revealed significant metabolic variation in pre-diabetic individuals that are distinct from known diabetes risk indicators, such as glycosylated hemoglobin levels, fasting glucose and insulin. We identified three metabolites (glycine, lysophosphatidylcholine (LPC) (18:2) and acetylcarnitine) that had significantly altered levels in IGT individuals as compared to those with normal glucose tolerance, with P-values ranging from 2.4 × 10-4 to 2.1 × 10-13. Lower levels of glycine and LPC were found to be predictors not only for IGT but also for T2D, and were independently confirmed in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam cohort. Using metabolite-protein network analysis, we identified seven T2D-related genes that are associated with these three IGT-specific metabolites by multiple interactions with four enzymes. The expression levels of these enzymes correlate with changes in the metabolite concentrations linked to diabetes. Our results may help developing novel strategies to prevent T2D.

Original languageEnglish
Article number615
JournalMolecular Systems Biology
Volume8
DOIs
Publication statusPublished - 2012
Externally publishedYes

Fingerprint

Metabolomics
Glucose Intolerance
Diabetes
Biomarkers
metabolomics
glucose tolerance
Medical problems
Type 2 Diabetes Mellitus
diabetes
Glucose
biomarkers
noninsulin-dependent diabetes mellitus
Metabolites
metabolites
Tolerance
Lysophosphatidylcholines
lysophosphatidylcholine
Glycine
Fasting
Acetylcarnitine

Keywords

  • early diagnostic biomarkers
  • IGT
  • metabolomics
  • prediction
  • T2D

ASJC Scopus subject areas

  • Medicine(all)
  • Immunology and Microbiology(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Agricultural and Biological Sciences(all)
  • Computational Theory and Mathematics
  • Information Systems
  • Applied Mathematics

Cite this

Wang-Sattler, R., Yu, Z., Herder, C., Messias, A. C., Floegel, A., He, Y., ... Illig, T. (2012). Novel biomarkers for pre-diabetes identified by metabolomics. Molecular Systems Biology, 8, [615]. https://doi.org/10.1038/msb.2012.43

Novel biomarkers for pre-diabetes identified by metabolomics. / Wang-Sattler, Rui; Yu, Zhonghao; Herder, Christian; Messias, Ana C.; Floegel, Anna; He, Ying; Heim, Katharina; Campillos, Monica; Holzapfel, Christina; Thorand, Barbara; Grallert, Harald; Xu, Tao; Bader, Erik; Huth, Cornelia; Mittelstrass, Kirstin; Döring, Angela; Meisinger, Christa; Gieger, Christian; Prehn, Cornelia; Roemisch-Margl, Werner; Carstensen, Maren; Xie, Lu; Yamanaka-Okumura, Hisami; Xing, Guihong; Ceglarek, Uta; Thiery, Joachim; Giani, Guido; Lickert, Heiko; Lin, Xu; Li, Yixue; Boeing, Heiner; Joost, Hans Georg; De Angelis, Martin Hrabé; Rathmann, Wolfgang; Suhre, Karsten; Prokisch, Holger; Peters, Annette; Meitinger, Thomas; Roden, Michael; Wichmann, H. Erich; Pischon, Tobias; Adamski, Jerzy; Illig, Thomas.

In: Molecular Systems Biology, Vol. 8, 615, 2012.

Research output: Contribution to journalArticle

Wang-Sattler, R, Yu, Z, Herder, C, Messias, AC, Floegel, A, He, Y, Heim, K, Campillos, M, Holzapfel, C, Thorand, B, Grallert, H, Xu, T, Bader, E, Huth, C, Mittelstrass, K, Döring, A, Meisinger, C, Gieger, C, Prehn, C, Roemisch-Margl, W, Carstensen, M, Xie, L, Yamanaka-Okumura, H, Xing, G, Ceglarek, U, Thiery, J, Giani, G, Lickert, H, Lin, X, Li, Y, Boeing, H, Joost, HG, De Angelis, MH, Rathmann, W, Suhre, K, Prokisch, H, Peters, A, Meitinger, T, Roden, M, Wichmann, HE, Pischon, T, Adamski, J & Illig, T 2012, 'Novel biomarkers for pre-diabetes identified by metabolomics', Molecular Systems Biology, vol. 8, 615. https://doi.org/10.1038/msb.2012.43
Wang-Sattler R, Yu Z, Herder C, Messias AC, Floegel A, He Y et al. Novel biomarkers for pre-diabetes identified by metabolomics. Molecular Systems Biology. 2012;8. 615. https://doi.org/10.1038/msb.2012.43
Wang-Sattler, Rui ; Yu, Zhonghao ; Herder, Christian ; Messias, Ana C. ; Floegel, Anna ; He, Ying ; Heim, Katharina ; Campillos, Monica ; Holzapfel, Christina ; Thorand, Barbara ; Grallert, Harald ; Xu, Tao ; Bader, Erik ; Huth, Cornelia ; Mittelstrass, Kirstin ; Döring, Angela ; Meisinger, Christa ; Gieger, Christian ; Prehn, Cornelia ; Roemisch-Margl, Werner ; Carstensen, Maren ; Xie, Lu ; Yamanaka-Okumura, Hisami ; Xing, Guihong ; Ceglarek, Uta ; Thiery, Joachim ; Giani, Guido ; Lickert, Heiko ; Lin, Xu ; Li, Yixue ; Boeing, Heiner ; Joost, Hans Georg ; De Angelis, Martin Hrabé ; Rathmann, Wolfgang ; Suhre, Karsten ; Prokisch, Holger ; Peters, Annette ; Meitinger, Thomas ; Roden, Michael ; Wichmann, H. Erich ; Pischon, Tobias ; Adamski, Jerzy ; Illig, Thomas. / Novel biomarkers for pre-diabetes identified by metabolomics. In: Molecular Systems Biology. 2012 ; Vol. 8.
@article{164bdc16060747acbd64a9037e5003cd,
title = "Novel biomarkers for pre-diabetes identified by metabolomics",
abstract = "Type 2 diabetes (T2D) can be prevented in pre-diabetic individuals with impaired glucose tolerance (IGT). Here, we have used a metabolomics approach to identify candidate biomarkers of pre-diabetes. We quantified 140 metabolites for 4297 fasting serum samples in the population-based Cooperative Health Research in the Region of Augsburg (KORA) cohort. Our study revealed significant metabolic variation in pre-diabetic individuals that are distinct from known diabetes risk indicators, such as glycosylated hemoglobin levels, fasting glucose and insulin. We identified three metabolites (glycine, lysophosphatidylcholine (LPC) (18:2) and acetylcarnitine) that had significantly altered levels in IGT individuals as compared to those with normal glucose tolerance, with P-values ranging from 2.4 × 10-4 to 2.1 × 10-13. Lower levels of glycine and LPC were found to be predictors not only for IGT but also for T2D, and were independently confirmed in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam cohort. Using metabolite-protein network analysis, we identified seven T2D-related genes that are associated with these three IGT-specific metabolites by multiple interactions with four enzymes. The expression levels of these enzymes correlate with changes in the metabolite concentrations linked to diabetes. Our results may help developing novel strategies to prevent T2D.",
keywords = "early diagnostic biomarkers, IGT, metabolomics, prediction, T2D",
author = "Rui Wang-Sattler and Zhonghao Yu and Christian Herder and Messias, {Ana C.} and Anna Floegel and Ying He and Katharina Heim and Monica Campillos and Christina Holzapfel and Barbara Thorand and Harald Grallert and Tao Xu and Erik Bader and Cornelia Huth and Kirstin Mittelstrass and Angela D{\"o}ring and Christa Meisinger and Christian Gieger and Cornelia Prehn and Werner Roemisch-Margl and Maren Carstensen and Lu Xie and Hisami Yamanaka-Okumura and Guihong Xing and Uta Ceglarek and Joachim Thiery and Guido Giani and Heiko Lickert and Xu Lin and Yixue Li and Heiner Boeing and Joost, {Hans Georg} and {De Angelis}, {Martin Hrab{\'e}} and Wolfgang Rathmann and Karsten Suhre and Holger Prokisch and Annette Peters and Thomas Meitinger and Michael Roden and Wichmann, {H. Erich} and Tobias Pischon and Jerzy Adamski and Thomas Illig",
year = "2012",
doi = "10.1038/msb.2012.43",
language = "English",
volume = "8",
journal = "Molecular Systems Biology",
issn = "1744-4292",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Novel biomarkers for pre-diabetes identified by metabolomics

AU - Wang-Sattler, Rui

AU - Yu, Zhonghao

AU - Herder, Christian

AU - Messias, Ana C.

AU - Floegel, Anna

AU - He, Ying

AU - Heim, Katharina

AU - Campillos, Monica

AU - Holzapfel, Christina

AU - Thorand, Barbara

AU - Grallert, Harald

AU - Xu, Tao

AU - Bader, Erik

AU - Huth, Cornelia

AU - Mittelstrass, Kirstin

AU - Döring, Angela

AU - Meisinger, Christa

AU - Gieger, Christian

AU - Prehn, Cornelia

AU - Roemisch-Margl, Werner

AU - Carstensen, Maren

AU - Xie, Lu

AU - Yamanaka-Okumura, Hisami

AU - Xing, Guihong

AU - Ceglarek, Uta

AU - Thiery, Joachim

AU - Giani, Guido

AU - Lickert, Heiko

AU - Lin, Xu

AU - Li, Yixue

AU - Boeing, Heiner

AU - Joost, Hans Georg

AU - De Angelis, Martin Hrabé

AU - Rathmann, Wolfgang

AU - Suhre, Karsten

AU - Prokisch, Holger

AU - Peters, Annette

AU - Meitinger, Thomas

AU - Roden, Michael

AU - Wichmann, H. Erich

AU - Pischon, Tobias

AU - Adamski, Jerzy

AU - Illig, Thomas

PY - 2012

Y1 - 2012

N2 - Type 2 diabetes (T2D) can be prevented in pre-diabetic individuals with impaired glucose tolerance (IGT). Here, we have used a metabolomics approach to identify candidate biomarkers of pre-diabetes. We quantified 140 metabolites for 4297 fasting serum samples in the population-based Cooperative Health Research in the Region of Augsburg (KORA) cohort. Our study revealed significant metabolic variation in pre-diabetic individuals that are distinct from known diabetes risk indicators, such as glycosylated hemoglobin levels, fasting glucose and insulin. We identified three metabolites (glycine, lysophosphatidylcholine (LPC) (18:2) and acetylcarnitine) that had significantly altered levels in IGT individuals as compared to those with normal glucose tolerance, with P-values ranging from 2.4 × 10-4 to 2.1 × 10-13. Lower levels of glycine and LPC were found to be predictors not only for IGT but also for T2D, and were independently confirmed in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam cohort. Using metabolite-protein network analysis, we identified seven T2D-related genes that are associated with these three IGT-specific metabolites by multiple interactions with four enzymes. The expression levels of these enzymes correlate with changes in the metabolite concentrations linked to diabetes. Our results may help developing novel strategies to prevent T2D.

AB - Type 2 diabetes (T2D) can be prevented in pre-diabetic individuals with impaired glucose tolerance (IGT). Here, we have used a metabolomics approach to identify candidate biomarkers of pre-diabetes. We quantified 140 metabolites for 4297 fasting serum samples in the population-based Cooperative Health Research in the Region of Augsburg (KORA) cohort. Our study revealed significant metabolic variation in pre-diabetic individuals that are distinct from known diabetes risk indicators, such as glycosylated hemoglobin levels, fasting glucose and insulin. We identified three metabolites (glycine, lysophosphatidylcholine (LPC) (18:2) and acetylcarnitine) that had significantly altered levels in IGT individuals as compared to those with normal glucose tolerance, with P-values ranging from 2.4 × 10-4 to 2.1 × 10-13. Lower levels of glycine and LPC were found to be predictors not only for IGT but also for T2D, and were independently confirmed in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam cohort. Using metabolite-protein network analysis, we identified seven T2D-related genes that are associated with these three IGT-specific metabolites by multiple interactions with four enzymes. The expression levels of these enzymes correlate with changes in the metabolite concentrations linked to diabetes. Our results may help developing novel strategies to prevent T2D.

KW - early diagnostic biomarkers

KW - IGT

KW - metabolomics

KW - prediction

KW - T2D

UR - http://www.scopus.com/inward/record.url?scp=84867012919&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84867012919&partnerID=8YFLogxK

U2 - 10.1038/msb.2012.43

DO - 10.1038/msb.2012.43

M3 - Article

VL - 8

JO - Molecular Systems Biology

JF - Molecular Systems Biology

SN - 1744-4292

M1 - 615

ER -